SCHEMBL7399759

SCHEMBL7399759

OC1(c2ccc(Cl)cc2)CCN(CCCOc2ccccc2)CC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 3/20 0.78
HTR1A P08908 2/20 0.78
HTR2A P28223 2/20 0.78
DRD3 P35462 2/20 0.78
DRD1 P21728 1/20 0.78
DRD5 P21918 1/20 0.78
SLC6A2 P23975 1/20 0.78
SLC6A4 P31645 1/20 0.78
HTR7 P34969 1/20 0.78
HRH1 P35367 1/20 0.78
HTR2B P41595 1/20 0.78
MEN1 O00255 1/20 0.70
ALDH1A1 P00352 1/20 0.70
LMNA P02545 1/20 0.70
KMT2A Q03164 1/20 0.70
CCR3 P51677 4/20 0.67
CCR1 P32246 4/20 0.65
OPRM1 P35372 1/20 0.62
OPRL1 P41146 1/20 0.62
HRH3 Q9Y5N1 3/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7407915 0.94 DRD2 (0.68) DRD2HTR1AHTR2ADRD3DRD1
Hydrochloric Acid SCHEMBL7406946 0.92 DRD2 (0.67) DRD2HTR1AHTR2ADRD3DRD1
SCHEMBL11717047 0.91 ALDH1A1 (0.74) DRD2HTR1AHTR2ADRD3DRD1
SCHEMBL11844101 0.88 DRD2 (1.00) DRD2HTR1AHTR2ADRD3DRD1
SCHEMBL3575961 0.83 HTR1A (0.72) DRD2HTR1AHTR2ADRD3DRD1
SCHEMBL4743808 0.83 HRH4 (0.64) DRD2HTR1AHTR2ADRD3DRD1
SCHEMBL3580238 0.82 HRH3 (0.72) DRD2HTR1AHTR2ADRD3DRD1
SCHEMBL12646791 0.82 DRD2 (0.70) DRD2HTR1AHTR2ADRD3DRD1
Bromide SCHEMBL4688803 0.82 MEN1 (0.67) DRD2HTR1AHTR2ADRD3DRD1
SCHEMBL7402996 0.82 CCR3 (0.92) DRD2HTR1AHTR2ADRD3DRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6124323-A ACTIVE DRUG TREATING STROKE, CEREBRAL ISCHEMIA, CENTRAL NERVOUS SYSTEM TRAUMA, HYPOGLYCEMIA, ANXIETY, CONVULSIONS, AMIOGLYCOSIDE ANTIBIOTICS-INDUCED HEARING LOSS, MIGRAINE HEADACHES, CHRONIC PAIN, GLAUCOMA, CMV RETINITIS, PSYCHOSIS WARNER-LAMBERT COMPANY (US) 2000-09-26 US claimed
EP-0869792-A4 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER LAMBERT CO (US) 1999-09-22 EP claimed
EP-0869792-A2 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1998-10-14 EP claimed
WO-1997023216-A1 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1997-07-03 WO claimed
US-6124323-A ACTIVE DRUG TREATING STROKE, CEREBRAL ISCHEMIA, CENTRAL NERVOUS SYSTEM TRAUMA, HYPOGLYCEMIA, ANXIETY, CONVULSIONS, AMIOGLYCOSIDE ANTIBIOTICS-INDUCED HEARING LOSS, MIGRAINE HEADACHES, CHRONIC PAIN, GLAUCOMA, CMV RETINITIS, PSYCHOSIS WARNER-LAMBERT COMPANY (US) 2000-09-26 US disclosed
EP-0869792-A4 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER LAMBERT CO (US) 1999-09-22 EP disclosed
EP-0869792-A2 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1998-10-14 EP disclosed
WO-1997023216-A1 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1997-07-03 WO disclosed